Drugs / Lu AF35700
Trials 12 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 19 trials | ||||||
| Phase 1 | NCT03670082 | Sep → Dec 2018 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT03241147 | Jul 2017 → Jul 2019 | kidney failure | H. Lundbeck A/S | Terminated | No outcome recorded |
| Phase 1 | NCT03195946 | Jun 2017 → Jan 2018 | hypersensitivity reaction disease | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT03189615 | May 2017 → Feb 2018 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT03103646 | Mar 2017 → Apr 2019 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT02901587 | Sep 2016 → Apr 2018 | schizoaffective disorder, schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT02333487 | Dec 2014 → Feb 2016 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT02093169 | Feb → Jun 2014 | — | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 1 | NCT02202226 | Jan 2013 → Feb 2015 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT03230864 | Jul 2017 → Dec 2018 | schizophrenia | H. Lundbeck A/S | Terminated | No outcome recorded |
| Phase 3 | NCT02892422 | Aug 2016 → Oct 2019 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
| Phase 3 | NCT02717195 | Apr 2016 → Aug 2018 | schizophrenia | H. Lundbeck A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 12 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AF35700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02892422 ↗ |
| Route | Oral | “orally” NCT02093169 ↗ |